Introduction
============

Experimental studies have demonstrated that magnesium (Mg) therapy can protect the ischemic myocardium and modulate reperfusion injury. In myocardial infarction the reperfusion injury is further complicated by the presence of a thrombogenic area in the affected coronary artery that may lead to repetitive reocclusion and embolisation.

Methods
=======

We investigated the effect of Mg on infarct size in a randomised, blinded study in pigs inflicted with a thrombogenic lesion in the left anterior descending artery (LAD) and mechanical occlusion of the vessel proximal to the lesion. Coronary occlusion was maintained for 50 min followed by 4 h reperfusion. Magnesium sulphate (6 mmol/30 min followed by 3 mmol/h) or saline was given at 20 min of coronary occlusion and continued for 4 h. ^111^Indium-labeled platelets were given 30 min prior to harvesting of the hearts. Troponin-T (TNT) was measured at base-line and 3 h into reperfusion.

Results
=======

The infarct size/area at risk (IS/AR) ratio in the placebo group was 40 (35--63)% (*n* = 8) compared with 16 (9--40)% (*n* = 6) in the Mg treated animals (*P* \< 0.05). Platelet accumulation in AR was reduced with 15% in the Mg treated animals \[placebo-group: 194 (157--205)% vs Mg-group: 166(131--213)%; NS\]. Cellular leakage of TNT increased significantly in both groups and was at 3 h highest in the placebo group: 1.7 (0.6--3.5 μg/l compared to 0.3 (0.1--1.5) μg/l in the Mg-treated animals (NS).

Conclusion
==========

The present study demonstrates that iv Mg infusion is able to reduce infarct size with more than 50% in this model where an ischaemia/reperfusion injury was combined with endothelial damage in the nutrient artery. The reduction in infarct size may be due to complementary actions on platelets and a cellular protection of the myocardium.
